Atlas Trials

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Clinical trial NCT06212583 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06212583
Sponsor
University of Maryland, Baltimore
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerOligometastatic Disease
Start date
2024-04-17
Primary completion
2028-12-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.